Cyrus Khandanpour Profile
Cyrus Khandanpour

@c_khandanpour

Followers
399
Following
3K
Statuses
3K

Father, husband, Associate professor „translational cancer research“at Department of Haematology and Oncology at UKSH Campus Lübeck

Lübeck, Germany
Joined June 2016
Don't wanna be here? Send us removal request.
@c_khandanpour
Cyrus Khandanpour
2 days
RT @bdermanmd: Median f/u: 27 months 🦴MRD<10^-5 + CR rate: 37% [same as Isa-VRd in BENEFIT] ‼️ 39 pts completed 18 cycles. 14 (27%) d/c'd…
0
1
0
@c_khandanpour
Cyrus Khandanpour
2 days
@HDMyeloma @SciImmunology @haas_lab a great and clinically important study
0
0
0
@c_khandanpour
Cyrus Khandanpour
2 days
Great team and great work
@RaabMarc
Marc S. Raab
3 days
So proud of our team @HDMyeloma !
Tweet media one
0
0
0
@c_khandanpour
Cyrus Khandanpour
2 days
RT @Myeloma_Doc: #Myeloma Paper of the Day: Cohort study of patients w/ #MGUS (IgG, IgA, or light chain) from nationwide US Veterans Healt…
0
8
0
@c_khandanpour
Cyrus Khandanpour
3 days
RT @Myeloma_Doc: #Myeloma Paper of the Day: Phase 3 CEPHEUS study of Dara+VRd vs. VRd finds MRD-negativity 60.9% for quad vs. 39.4% w/ VRd;…
0
20
0
@c_khandanpour
Cyrus Khandanpour
4 days
RT @HDMyeloma: 📣 We are excited to announce the 10th Heidelberg Myeloma Workshop   Join us on April 25–26, 2025, as international & local e…
0
12
0
@c_khandanpour
Cyrus Khandanpour
13 days
RT @Amin_Turki_MD: Proud #mentor for the @EHA_Hematology 2025 #mentorship program. @young_eha fellow and mentee applications are still ope…
0
1
0
@c_khandanpour
Cyrus Khandanpour
18 days
RT @BloodJournal: Daratumumab for maintenance in myeloma #clinicaltrialsandobservations
0
14
0
@c_khandanpour
Cyrus Khandanpour
18 days
Tweet media one
Tweet media two
0
9
0
@c_khandanpour
Cyrus Khandanpour
18 days
RT @MrinalPatnaik: Single-cell multiomics reveal divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response…
0
10
0
@c_khandanpour
Cyrus Khandanpour
18 days
RT @YanHu41082612: Super excited to share our new study from the @JD_Buenrostro Lab in @Nature! We developed a computational method for tra…
0
130
0
@c_khandanpour
Cyrus Khandanpour
18 days
RT @SuyogCancer: Slide of day 1 of #GI25 . How to treat Esophageal /GEJ cancer in 2025 ? Spot on by @NiuSanford @KrishanJethwa @ASCO #GI25
0
70
0
@c_khandanpour
Cyrus Khandanpour
1 month
@Rotkreuzklinikum München GGmbH, Centrum für Hämatologie und Onkologie Bethanien. Wenn Sie an den Artikel nicht drankommen, gerne mich anschreiben.
0
0
0
@c_khandanpour
Cyrus Khandanpour
1 month
RT @AhmedKo45911157: 🔬#FLT3 Inhibitors choice in #AML: Midostaurin vs. Quizartinib 📊Midostaurin: Targets FLT3-ITD & FLT3-TKD QTc <500ms Fav…
0
22
0
@c_khandanpour
Cyrus Khandanpour
1 month
RT @NicoGagelmann: Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma @NEJM - reduces risk of progression to acti…
0
3
0